Abstract:Objective To investigate the molecular mechanism of sterol regulatory element binding protein-1c (SREBP-1c) suppressing insulin receptor substrate-1(IRS-1) in skeletal muscle cells. Methods Luciferase plasmid for rat IRS-1 promoter, expression plasmid of SREBP-1c and pRL-TK renilla plasmid were cotransfected into L6 cells using Lipofectamine 2000 (Invitrogen). After transfection for 36 h, luciferase activity was measured using the dual-luciferase reporter assay system following the manufacturer' s instructions. L6 myotubes were infected with adenoviral vectors expressing SREBP-1c. Adenovirus expressing green fluorescent protein (GFP) was used as control. The cells were harvested for nucleus protein after infection for 48 h. Electrophoretic mobility shift assay (EMSA) was performed using a Light Shift Chemiluminescent EMSA Kit. Chromatin immunoprecipitation assay was performed by CHIP Kit. The interaction between the transcription factor SREBP-1c and the promoter region of IRS-1 was assessed by above experiments. Differences among the groups were determined using two-way ANOVA. Results The luciferase deletion studies suggested the region from-450 to-210 bp on the IRS-1 promoter was a potential target region for SREBP-1c. Sequence analysis showed that the target region of the rat IRS-1 promoter gene contained a potential binding site (GCCTCCCGAG), which was located between-302 and-292 bp. PCR site-directed mutagenesis (TGTTAAATTA) was generated and analyzed using a luciferase assay. The transcriptional activity of wild-type IRS-1 promoter was dramatically down-regulated by SREBP-1c, whereas SREBP-1c had no effect on the IRS-1 promoter bearing mutation of SREBP-1c binding site(7.03 ± 1.28 vs 19.09 ± 2.45,3.55 ± 1.68 vs 3.96 ± 1.09,F=114.437,0.251,all P>0.05). The EMSA results showed that the labeled wild-type probe successfully formed a complex with nuclear proteins. But the unlabelled mutant probe did not interfere the complex. The results from CHIP assay showed that SREBP-1c could bind directly to the IRS-1 promoter region. The quantity of SREBP-1c protein binding to the IRS-1 promoter was two times of control under PA conditions in L6 cells or five times of control when SREBP-1c was over-expressed (2.15 ± 0.03 vs 1.07 ± 0.24,5.48 ± 1.28 vs 0.86 ± 0.19,t=6.877,5.495,all P<0.05). Conclusion SREBP-1c could directly bind to the atypical SRE sequence in the promoter region of IRS-1, suppressing IRS-1 expression and the subsequent insulin signaling pathway.

Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription

[Effects of Transcription Factor Sterol Regulatory Element Binding Protein-1C in Palmitate Acid-Induced L6 Cells Insulin Resistance and Its Mechanism].

The Molecular Mechanism of Sterol Regulatory Element Binding Protein-1C Suppressing Insulinreceptor Substrate-1 in Skeletal Muscle

The Regulatory Effects of Sterol Regulatory Element Binding Protein-1C on Insulin Receptor Substrate-1 in Skeletal Muscle

Regulatory effects of insulin on sterol regulatory element binding protein-1c in skeletal muscle cells

Suppression of Rho-kinase 1 is Responsible for Insulin Regulation of the AMPK/SREBP-1c Pathway in Skeletal Muscle Cells Exposed to Palmitate

Anhydroicaritin Improves Diet-Induced Obesity and Hyperlipidemia and Alleviates Insulin Resistance by Suppressing SREBPs Activation

Effects of Early Insulin Therapy on Sterol Regulatory Element Binding Protein-1C in Skeletal Muscle of Diabetic Rats

Metformin ameliorates PA-induced skeletal muscle insulin resistance by suppressing SREBP-1c

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

291-LB: Long Noncoding RNA H19 Improves Insulin Resistance in Skeletal Muscle by Regulating Heterogeneous Nuclear Ribonucleoprotein A1

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Metformin Attenuates Palmitic Acid-Induced Insulin Resistance In L6 Cells Through The Amp-Activated Protein Kinase/Sterol Regulatory Element-Binding Protein-1c Pathway

Long non-coding RNA H19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1

Sterol Regulatory Element-Binding Protein-1C Activates Patatin Like Phospholipase Domain Containing 3 Gene Transcription in Rats

Programmed cell death 5 improves skeletal muscle insulin resistance by inhibiting IRS-1 ubiquitination through stabilization of MDM2

Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function

A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors

Hepatokine ERAP1 Disturbs Skeletal Muscle Insulin Sensitivity Via Inhibiting USP33-Mediated ADRB2 Deubiquitination

Increased Carnitine Palmitoyl Transferase 1 Expression and Decreased Sterol Regulatory Element–binding Protein 1c Expression Are Associated with Reduced Intramuscular Triglyceride Accumulation after Insulin Therapy in High-Fat–diet and Streptozotocin-Induced Diabetic Rats